Cancer News and Research

Latest Cancer News and Research

American Recovery and Reinvestment Act funds to support research in numerous health areas

As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.

14 Oct 2009

Conseco complies with Regulation FD, to post certain important information on its website

Conseco, Inc. announced today that, in compliance with Regulation FD and to ensure that all investors have equal access to information, it will post certain important information on its website after 5:30 p.m. on Tuesday, October 13, 2009.

14 Oct 2009

Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine

Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.

14 Oct 2009

Bladder cancer patients benefit from anticancer drug that is used to treat lung and colon malignancies: Study

An anticancer drug that is commonly used to treat lung and colon malignancies is having a benefit and potentially prolonging survival in patients with invasive bladder cancer, researchers reported at the 2009 Clinical Congress of the American College of Surgeons.

14 Oct 2009

Case Western Reserve University receives a $20.5M gift to support medical education and research programs

Case Western Reserve University has received a $20.5 million gift from Donald Goodman, DDS (DEN '45) and Ruth Weber Goodman.

14 Oct 2009

Timely and individualized publicly funded therapy denied to children with autism

With October being Autism Awareness Month in Canada, Ontarians should be aware of the increasingly large gaps in services for children with autism in this province.

14 Oct 2009

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery.

14 Oct 2009

Kaiser Permanente receives $54 million grant from NIH to conduct health research

14 Oct 2009

Breast tenderness indicates increased cancer risk among women on combination therapy

Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.

13 Oct 2009

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

13 Oct 2009

NIH awards fund to Kaiser Permanente and UCSF for genetic epidemiology research

The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the University of California, San Francisco (UCSF) have been awarded $24.8 million over two years by the National Institutes of Health (NIH) to create a new resource for studying disease, health, and aging.

13 Oct 2009

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.

13 Oct 2009

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research

Compugen Ltd. announced today that they have signed a collaboration agreement with Bayer Schering Pharma AG, Germany covering the further evaluation of a Compugen discovered tumor target and its splice variants.

13 Oct 2009

Virginia Health Information releases HMO quality and satisfaction reports

Virginia Health Information (VHI), a nonprofit health information company, reports HMO quality and satisfaction reports at www.vhi.org.

13 Oct 2009

Sixth annual Medical Student Research Forum highlights latest findings

Members of Qatar's research and medical community recently gathered at Weill Cornell Medical College in Qatar to learn more about research conducted by the college's pre-medical and medical students.

13 Oct 2009

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Proteolix, Inc. today announced that it has signed a definitive agreement to be acquired by Onyx Pharmaceuticals, Inc.

13 Oct 2009

Exhibitors display latest biotechnology products and applications at BIOTECHNICA 2009

Chalking up an increase in the number of exhibitors and trade visitors plus the amount of display space sold, the BIOTECHNICA, exhibition (6 to 8 October 2009) sent some important signals in the midst of an economic crisis.

13 Oct 2009

Statistical model helps identify patients who need to undergo further cancer treatment

A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy. The analysis, to be published in the December 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, concludes that the model, which considers both how far the cancer has spread and other information, such as how the cancer cells look under the microscope and the time between diagnosis and surgery, could better identify patients who need to undergo further treatment.

13 Oct 2009

SAFC Pharma expands contract manufacturing services

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced the completion of an addition to its Carlsbad, Calif., facility that expands the Company's contract manufacturing services for its late phase and commercial clients.

13 Oct 2009

Thomson Reuters's NeoFax deployed at the University of Kansas Hospital for electronic neonatal drug dosing

The University of Kansas Hospital has deployed NeoFax(®) from Thomson Reuters to provide physicians, nurses, and pharmacy staff in its neonatal intensive care unit with electronic drug dosing, interaction checking, and reference information.

13 Oct 2009

Cancer News and Research

Latest Cancer News and Research

American Recovery and Reinvestment Act funds to support research in numerous health areas

Conseco complies with Regulation FD, to post certain important information on its website

Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine

Bladder cancer patients benefit from anticancer drug that is used to treat lung and colon malignancies: Study

Case Western Reserve University receives a $20.5M gift to support medical education and research programs

Timely and individualized publicly funded therapy denied to children with autism

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

Kaiser Permanente receives $54 million grant from NIH to conduct health research

Breast tenderness indicates increased cancer risk among women on combination therapy

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

NIH awards fund to Kaiser Permanente and UCSF for genetic epidemiology research

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research

Virginia Health Information releases HMO quality and satisfaction reports

Sixth annual Medical Student Research Forum highlights latest findings

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Exhibitors display latest biotechnology products and applications at BIOTECHNICA 2009

Statistical model helps identify patients who need to undergo further cancer treatment

SAFC Pharma expands contract manufacturing services

Thomson Reuters's NeoFax deployed at the University of Kansas Hospital for electronic neonatal drug dosing

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cancer News and Research

Latest Cancer News and Research

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in